Quince Therapeutics Inc (QNCX)
1.06
+0.03
(+2.91%)
USD |
NASDAQ |
Apr 26, 16:00
1.06
0.00 (0.00%)
After-Hours: 20:00
Quince Therapeutics 1 Year Total Returns (Daily): -31.61% for April 26, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 26, 2024 | -31.61% |
April 25, 2024 | -33.55% |
April 24, 2024 | -31.61% |
April 23, 2024 | -29.75% |
April 22, 2024 | -32.91% |
April 19, 2024 | -29.05% |
April 18, 2024 | -30.72% |
April 17, 2024 | -36.31% |
April 16, 2024 | -35.29% |
April 15, 2024 | -34.74% |
April 12, 2024 | -39.17% |
April 11, 2024 | -34.21% |
April 10, 2024 | -34.87% |
April 09, 2024 | -34.76% |
April 08, 2024 | -36.59% |
April 05, 2024 | -38.62% |
April 04, 2024 | -41.90% |
April 03, 2024 | -40.68% |
April 02, 2024 | -32.69% |
April 01, 2024 | -30.13% |
March 28, 2024 | -29.80% |
March 27, 2024 | -23.65% |
March 26, 2024 | -24.16% |
March 25, 2024 | -19.46% |
March 22, 2024 | -17.24% |
Date | Value |
---|---|
March 21, 2024 | -18.75% |
March 20, 2024 | 36.64% |
March 19, 2024 | 45.78% |
March 18, 2024 | 43.37% |
March 15, 2024 | 36.39% |
March 14, 2024 | 31.42% |
March 13, 2024 | 29.67% |
March 12, 2024 | 25.01% |
March 11, 2024 | 21.89% |
March 08, 2024 | 16.57% |
March 07, 2024 | 17.17% |
March 06, 2024 | 17.28% |
March 05, 2024 | 22.22% |
March 04, 2024 | 18.18% |
March 01, 2024 | 34.61% |
February 29, 2024 | 40.15% |
February 28, 2024 | 44.46% |
February 27, 2024 | 40.69% |
February 26, 2024 | 35.58% |
February 23, 2024 | 33.00% |
February 22, 2024 | 26.21% |
February 21, 2024 | 30.10% |
February 20, 2024 | 42.11% |
February 16, 2024 | 36.17% |
February 15, 2024 | 42.68% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-98.83%
Minimum
Oct 10 2022
170.8%
Maximum
Aug 10 2021
-18.78%
Average
-31.90%
Median
1 Year Total Returns (Daily) Benchmarks
NovaBay Pharmaceuticals Inc | -94.23% |
Palatin Technologies Inc | -22.88% |
iBio Inc | -91.93% |
Theriva Biologics Inc | -34.45% |
Oragenics Inc | -63.21% |